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Abstract 
 
Objective: The APOE ε4 allele is an established risk factor for dementia, yet this genetic 
variant is associated with a mixed cognitive profile across the lifespan. This paper undertakes 
both a systematic and meta-analytic review of research investigating APOE-related 
differences in cognition in mid-adulthood, when detrimental effects of the allele may first be 
detectable. 
Method: 36 papers investigating the behavioural effects of APOE ε4 in mid-adulthood 
(defined as a mean sample age between 35-60 years) were reviewed. In addition, the effect of 
carrying an ε4 allele on individual cognitive domains was assessed in separate meta-analyses.  
Results: The average effect size of APOE ε4 status was non-significant across cognitive 
domains. Further consideration of genotype effects indicates preclinical effects of APOE ε4 
may be observable in memory and executive functioning. 
Conclusions: The cognitive profile of APOE ε4 carriers at mid-age remains elusive. Whilst 
there is support for comparable performance by ε4 and non-e4 carriers in the 5th decade, 
studies administering sensitive cognitive paradigms indicate a more nuanced profile of 
cognitive differences. Methodological issues in this field preclude strong conclusions, which 
future research must address, as well as considering the influence of further vulnerability 
factors on genotype effects.  
 
Keywords: Cognitive Aging, Middle-aged, Neuroimaging, Alzheimer Disease, Memory, 
Executive Function 
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Introduction 
Pathological cognitive ageing is an increasing problem worldwide, with 850,000 
cases of Alzheimer’s disease (AD) at present in the UK alone. With prevalence expected to 
double within the next 20 years (Alzheimer’s society, 2016), understanding the risk factors 
associated with dementia is crucial. The Apolipoprotein E (APOE) epsilon 4 (ε4) allele is the 
leading genetic risk factor for late-onset Alzheimer’s disease (Corder et al., 1993; Farrer et 
al., 1997). This variant of the APOE gene constitutes one of the three APOE alleles (ε2, ε3 
and ε4), present in approximately 25% of the population (Mahley, 1988).  
 
Systematic reviews of studies including healthy older adults support an association 
between possession of an ε4 allele and cognitive impairment in ageing more generally (Small, 
Rosnick, Fratiglioni, & Bäckman, 2004; Wisdom, Callahan, & Hawkins, 2011), although not 
all studies are consistent in reporting this effect (Bunce et al., 2014; Bunce, Kivipelto, & 
Wahlin, 2004; Caselli et al., 2014).  The association between ε4 and healthy cognitive ageing 
suggests the effects of this variant are not solely linked to neuropathology, and so a 
dimensional approach is needed to consider the overlap between healthy and pathological 
ageing (Walhovd, Fjell, & Espeseth, 2014). Potentially accounting for inconsistency within 
the older-adult literature, meta-analyses of study effect sizes suggest APOE-related 
differences are small and limited to certain classes of cognitive task, including global 
cognition, episodic memory, perceptual speed and executive function (EF) (Small et al., 2004; 
Wisdom et al., 2011). Age and gene-dose are also implicated as important moderators of ε4 
effects (Small et al., 2004). These factors are important for how we approach understanding 
APOE genotype differences.  
 
Curiously, the detrimental effects of APOE ε4 are not consistent across the lifespan, 
muddying attempts to explain the causality of this risk factor for decline. In naturalistic 
research, ε4 carriers (henceforth ε4+) were reported to have higher IQ and greater educational 
achievement than ε4 non-carriers (henceforth ε4-) (Hubacek et al., 2001; Yu, Lin, Chen, 
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Hong, & Tsai, 2000). This led to the hypothesis that ε4+ may show cognitive advantages 
earlier in life, with performance advantages similarly being demonstrated in some (Alexander 
et al., 2007; Han et al., 2007; Schultz et al., 2008), although not all (Bunce et al., 2014; 
Bunce, Anstey, Burns, Christensen, & Easteal, 2011; Jorm et al., 2007) studies assessing 
genotype differences with neuropsychological batteries. Importantly, no steps have been 
taken to explore the potential moderating effects of early-life IQ and education on the 
trajectory of cognitive ageing in ε4+ through longitudinal research.   
 
A meta-analytic review found no conclusive support for an ε4+ advantage in younger 
years (Ihle, Bunce, & Kliegel, 2012); however, the authors acknowledge conclusions may 
stem from the predominant inclusion of studies using quick to administer behavioural 
assessments. Such assessments are typically used for detecting clinically relevant cognitive 
differences rather than the subtle changes expected in young healthy adults. When 
considering evidence from research paradigms designed to sensitively index select cognitive 
processes, ε4+ advantages have been reported. Young ε4+ showed behavioural advantages 
compared to ε4- on a delayed episodic memory measure (Mondadori et al., 2007). 
Furthermore, Marchant, King, Tabet, & Rusted (2010) demonstrated an ε4+ advantage in 18-
30 year olds across a number of domains including prospective memory, decision-making and 
sustained attention. Advantages in sustained attention were replicated in a further study 
(Rusted et al., 2013), which also reported ε4+ advantages in covert attention (Rusted et al., 
2013). In addition, ε4+ show EF advantages up until age 50 (Taylor et al., 2016). While 
carrying an ε4 allele might promote cognitive advantages in youth, it is important to 
understand how early differences cumulatively impact on the ageing trajectory of ε4+.   
 
This review attempts to unravel the development of APOE ε4 cognitive effects by 
considering studies recruiting healthy mid-age volunteers. Mid-adulthood, as well as being 
influenced by the cumulative impact of APOE ε4 in younger years, may represent a stage 
when the detrimental effects of carrying this gene are first appearing. Additionally, mid-
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adulthood represents a period of emergence for further risk factors for dementia (e.g. 
declining vascular health), which may modulate the trajectory of cognitive ageing. By 
studying the impact of risk factors for cognitive decline during mid-adulthood, there is the 
potential to facilitate the early identification and prevention of cognitive decline. In 
combination, these motivations emphasise the theoretical interest of studying the effects of 
APOE ε4 at mid-age.  
 
Here, we present a systematic review of research investigating APOE differences in 
mid-adulthood, including studies administering neuropsychological assessment measures, 
process-specific paradigms, and those assessing change in cognition over time. In addition, 
ε4+ differences in individual cognitive domains are subject to a meta-analytic review. 
 
 
Methods 
 
Selection of studies 
 
This review was conducted in accordance with the Helsinki declaration.  A literature 
search of 3 databases (PsychInfo, Web of Science and Scopus) was conducted, using search 
terms including ‘APOE’, ‘Apolipoprotein’, ‘cognitive’, ‘cognition’, and ‘performance’ 1.  The 
search was limited to articles published post-1993 as this was when the link between APOE 
and detrimental cognitive ageing was first identified (Corder et al., 1993). Articles referenced 
by included papers were also considered if they aligned with the search criteria of this review. 
The last update for the search was conducted in July 2016.  An overview of the search 
procedure is given in Figure 1. 
																																																								1 The exact search terms were as follows: (Apolipoprotein E OR apoe OR Apoliopoprotein-E) AND 
(Cognition OR Behaviour OR Memory OR Performance OR Executive OR Attention OR Mid-age OR 
Adult OR Mid-adulthood). These key words must be found in the title or abstract of identified papers. 
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Eligibility criteria 
 
Studies were included in the review if they met the following criteria: (1) The study 
included volunteers grouped by APOE genotype, enabling the comparison of ε4+ to an ε4- 
group. (2) The mean age of volunteers in the study falls between 35-60 years. If no mean was 
available, the entire age range included must fall within 35-60 years. (3) The study included 
cognitively healthy adult volunteers. Studies including clinical groups, for example diagnosed 
with dementia, neural trauma or a psychiatric condition were excluded. (4) At least one 
objective measure of cognition must be included. (5) The study was published in English. In 
some cases, studies overlapped in reporting cognitive performance of the same sample, and so 
some papers were omitted from the review (e.g. Caselli, Chen, Lee, Alexander, & Reiman, 
2008; Zuelsdorff et al., 2013).  
 
Papers were included in the meta-analytic review if sufficient statistical data was 
provided for calculating the standardised effect size of carrying an ε4 allele on cognitive 
performance (mean, standard deviation (sd)) compared to an ε4- group. Study outcomes were 
included if task performance could be summarised by a measure of accuracy. Authors were 
contacted where insufficient data was provided.  
 
[INSERT FIGURE 1] 
Organisation of studies 
 
36 studies met criteria for being included in this review, 23 of which were included in 
the meta-analysis. Separate meta-analyses were completed for performance in 7 cognitive 
domains (global cognition, memory, executive abilities, verbal fluency, language, visuospatial 
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processing and processing speed). For the narrative review, studies were considered more 
broadly as those using neuropsychological assessment measures, those that administered more 
detailed research paradigms and longitudinal assessments. 
 
 
Statistical analysis 
 
For the outcome of each task included in the meta-analytic review, Hedge’s d was 
calculated as the difference in mean performance between ε4+ and ε4-, divided by the pooled 
sd. The unbiased estimate (Hedge’s g) was used in the analysis, with a positive effect size 
indicating stronger performance by the ε4+ group. In studies reporting multiple performance 
outcomes per cognitive domain, effect sizes were averaged across tasks (Borenstein, Hedges, 
Higgins, & Rothstein, 2009; De Costa, 2009) to prevent the overall effect size for any 
cognitive domain being over-biased by one sample. Multiple effect sizes were included when 
studies included more than one sample of ε4 + and ε4- grouped by another variable such as 
ethnicity or age (e.g. Blair et al., 2005; Shin et al., 2014). For each domain, a random-effects 
meta-analysis was completed. Tests of homogeneity were completed for each domain (QT, and 
I2) to check the validity of the model. A significant Q statistic indicates a non-homogenous 
distribution of effect sizes. The I2 was used to further validate this statistic, as it is not 
dependent on the number of studies included. Where heterogeneity was detected, data was 
screened for outliers based on the standardised weight of residuals and the difference 
excluding a study made to heterogeneity. 
 
Results 
 
Table 1 presents a summary of cross-sectional studies included in this review, 
including details of the sample demographics and cognitive tasks administered. A further 
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summary of the studies included in each meta-analysis and the associated effect sizes are 
shown in Table 2.  
 
[INSERT TABLE 1] 
[INSERT TABLE 2] 
 
Meta-analyses 
 
A summary of the results from each meta-analytic model is provided in Table 3.  
Forest plots demonstrating the distribution of effect sizes per domain are shown in Figure 2. 
 
Global 
 
A meta-analysis of effect sizes from 9 studies assessing global cognition found 
carrying an ε4 allele had a non-significant effect on performance, d=.03, p>.05. Tests for 
homogeneity indicated moderate heterogeneity in the individual studies’ effect sizes, 
Q(8)=15.88, p=.044, I2=48.36%. Data was screened for outliers, with a sample aged 55-64 
years (Shin et al., 2014) identified as substantially increasing heterogeneity. With this effect 
size removed, carrying an ε4 allele had a positive effect on global cognitive performance in 
mid-adulthood, with the effect size approaching significance, d=.09, p=.066 (Q(7)=5.20, 
p>.05, I2=0%). 
 
Memory 
 
Effect sizes from 20 studies were included in a meta-analysis of APOE ε4 effects on 
memory; ε4+ status had a non-significant effect on performance (d=-.01, p>.05). Again, there 
was moderate heterogeneity in the sample of effect sizes, Q(19)=48.38, p<.001, I2=10%. 
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After screening for outliers the effect size from Levy et al., (2004) was removed, but the 
average effect size remained non-significant (d=-.01, p>.05)(Q(18)=17.40, p>.05, I2=0%).  
 
Executive abilities 
 
Effect sizes from 12 studies were included in a meta-analysis of APOE ε4 effects on 
executive skills. ε4+ status did not significantly influence performance (d=-.03, p>.05). There 
was no significant heterogeneity in this collection of effect sizes, Q(11)=8.60, p>.05, I2=0%. 
 
Verbal fluency 
 
10 studies contributed effect sizes to a meta-analysis of ε4+ effects on fluency 
performance. The average effect of APOE genotype was non-significant (d=.02, p>.05). 
There was no significant heterogeneity in this sample of effect sizes, Q(9)=8.17, p>.05, 
I2=21.25%. 
 
Language 
 
Effect sizes from 8 studies were included in a meta-analysis which found no 
significant effect of carrying an ε4 allele on language performance (d=.00, p>.05). There was 
no significant heterogeneity in this sample of effect sizes, Q(7)=6.81, p>.05, I2=26.65%. 
 
Visuospatial 
 
Effect sizes from 5 studies were included in the meta-analysis. There was no 
significant effect of carrying an ε4 allele on visuospatial performance (d=-.01, p>.05), with 
non-significant heterogeneity reported in the sample of effect sizes, Q(4)=2.78, p>.05, 
I2=11.96%. 
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Processing speed 
 
Seven studies contributed effect sizes to a meta-analysis of genotype differences in 
processing speed. The average effect of carrying an ε4 allele was non-significant (d=-.01, 
p>.05). There was no significant heterogeneity in this sample of effect sizes, Q(6)=7.15, 
p>.05, I2=0%. 
[Insert Table 3] 
[Insert Figure 2] 
 
Systematic review 
 
Neuropsychological Assessment  
 
The majority of studies examining the effect of APOE ε4 in mid-adulthood have 
chosen to administer a compilation of neuropsychological assessment measures. These studies 
report limited effects of APOE ε4 in mid-adulthood (e.g. Jorm et al., 2007; Marioni et al., 
2016; Sager, Hermann, & La Rue, 2005; Shin et al., 2014; Zhao et al., 2005). Indeed, in a 
large community-based sample, the effect of APOE status was non-significant in both mid-
adulthood (40-44 years), as well as groups aged 20-24 years and 60-64 years (Jorm et al., 
2007), leading authors to conclude there are no preclinical effects of APOE genotype on 
cognition. Of interest, however, other studies suggest sample age is a key determinant in the 
expression of preclinical APOE ε4 effects. Age x APOE interactions were found both for 
scores on the Korean MMSE (Shin et al., 2014), and performance on measures of declarative 
memory and processing speed (Marioni et al., 2016). In both studies, detrimental effects of 
ε4+ status emerged when analyses isolated volunteers aged in the latter half of the 5th decade 
(55+ years and 60+ years respectively).  
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Mid-age studies investigating APOE differences across a broad range of 
neuropsychological measures typically observe ε4+ effects, when present, within a select 
domain. For example, in the research of Sager et al. (2005) ε4+ selectively showed worse 
performance on visuospatial processing tasks, driven by decrements on block design 
performance. In contrast, detrimental effects of ε4+ status were limited to female participants 
on tasks probing memory and semantic fluency (Zhao et al., 2005), whereas ε4+ advantages 
were reported in verbal fluency and language across the adult lifespan by Marioni et al., 
(2016). While the selectivity of effects agrees with reports of genotype effects in older 
adulthood (Small et al., 2004; Wisdom et al., 2011), failure to identify a consistent pattern of 
ε4 effects within a cognitive domain in mid-adulthood makes interpretation difficult.  
 
Results within the domain of memory offer the clearest profile of cognitive 
differences in ε4+, with several studies associating possession of an ε4 allele with poorer 
memory performance (Caselli et al., 1999; Flory, Manuck, Ferrell, Ryan, & Muldoon, 2000; 
Goveas et al., 2013; Levy et al., 2004; Schultz et al., 2008). Attempts have been made to link 
differential memory performance with neural differences. In adults aged 44-65 years, ε4+ 
showed a trend of worse performance on the Rey Auditory Verbal Learning Test (AVLT) 
(Goveas et al., 2013). Performance on this task correlated with observed reductions in the 
functional connectivity of medial temporal lobe (MTL) circuits, as well as differential 
connectivity of the default mode network (Li et al., 2014; Goveas et al., 2013), offering a 
possible neurobiological basis of genotype differences. In addition, two studies report an 
altered BOLD response in ε4+ during episodic memory tasks, despite no detectable genotype 
difference in behavioural performance (Trachtenberg et al., 2012; Xu et al., 2009). Although 
this raises the question of how neural activations relate to cognition, identifying the neural 
basis of APOE differences will further mechanistic explanations of how APOE ε4 influences 
cognitive ageing.  
 
APOE: the cognitive profile in mid-adulthood	
	 12	
Research has started to explore how carrying an APOE ε4 allele interacts with 
environmental factors in influencing performance on neuropsychological measures. Education 
was found to interact with APOE status in a cohort of adults aged 45-54 years, in that only 
ε4+ with no formal education showed cognitive advantages on a measure of global cognition 
compared to their ε4- peers (Shin et al., 2014). In contrast, APOE, education and socio-
economic status were reported to independently affect cognition (Zhao et al., 2005).  
 
Considering cardiovascular health factors, an APOE x Blood Pressure interaction has 
been reported for cognition in mid-adulthood. Although there was no main effect of APOE 
status or systolic blood pressure on performance across 3 cognitive domains; episodic 
memory, visual memory or EF, in ε4+ only, high blood pressure was associated with worse 
episodic memory performance (Oberlin et al., 2015). High blood pressure was also found to 
enhance the negative association of APOE ε4 with processing speed and working memory 
(WM), as well as reduced white matter integrity in frontal regions (Bender & Raz, 2012). In 
both studies, the relationship between blood pressure and cognition was absent in the ε4- 
group, suggesting cardiovascular health factors may exaggerate cognitive effects in ε4+.   
 
 
Behavioural paradigms 
 
Paradigms designed to detect subtle differences in cognition have predominantly been 
used to explore the sensitivity of executive abilities, including WM and attention, to APOE 
effects in mid-adulthood.  
 
On a measure of covert attention, there was a non-significant effect of APOE 
genotype on overall performance, and on the ability to benefit from valid cues in mid-
adulthood (Greenwood, Sunderland, Friz, & Parasuraman, 2000). ε4+, however, showed 
increased response time costs following an invalid cue, relative to ε4- peers, interpreted as a 
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deficit in attentional disengagement. In contrast, a more recent study reported equivalent 
performance between genotype groups on this task (Evans et al., 2013; Evans, Dowell, Tabet, 
Tofts, King & Rusted, 2014). Control of visual attention was explored in an attentional 
scaling task (Greenwood et al., 2000; Greenwood, Lambert, Sunderland & Parasuraman, 
2005a). The dynamic scaling task measures the ability to constrict one’s attentional spotlight 
in response to top-down information cueing the spatial location of a target stimulus. ε4+ did 
not show the same benefit as their ε4- peers in response times following more precise cues. 
 
Executive attention was explored in a cross-sectional comparison of mid-age (aged 
43-58) and young adults (aged 18-30) (Evans et al., 2013; 2014). On a measure of sustained 
attention, a trend of higher accuracy, coupled with slower reaction times, was found in mid-
age ε4+ relative to their ε4- peers. When compared to the data from the young group, the mid-
age ε4+ group showed exaggerated age-related slowing. In comparison, a second study found 
no effect of APOE genotype on a similar task in adults aged 50+ (M=59 years) (Greenwood et 
al., 2000). A comparable pattern of results was seen on a prospective memory task, probing 
attentional monitoring and switching between goals. ε4+ demonstrated greater accuracy but 
slower response times on the prospective memory paradigm, suggestive of a speed-accuracy 
trade-off (Evans et al., 2013; 2014). Corresponding functional activations during this task 
indicated greater recruitment of frontal regions, but reduced recruitment of parietal and 
extrastriate visual regions in ε4+ relative to their ε4- peers. Specifically, left inferior frontal 
gyrus activity correlated with prospective memory accuracy in ε4+ only, consistent with an 
early compensatory shift towards reliance on more frontal systems. 
 
Genotype effects were explored using a selection of cognitive paradigms designed to 
probe the 3 components of executive function identified by Miyake et al. (2000): inhibition, 
switching and updating in WM (Velichkovsky, Roschina, & Selezneva, 2015). No genotype 
differences were recorded on either an anti-saccade inhibition measure, or two WM 
paradigms (n-back test, the operation span task).  A non-significant effect of APOE ε4 status 
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on n-back performance has previously been reported in middle-aged adults (Chen et al., 2013; 
Yan, Wu, Chao, Chen, & Tseng, 2015). Both studies, however, reported a differential pattern 
of neural change in ε4+, with this group showing an absence of neural activation increases in 
correspondence to greater WM load (Chen et al., 2013; Yan et al., 2015). This was interpreted 
as ε4+ maximally recruiting processing resources at a lower level of load, which cannot be 
further increased under greater demands. Hence, it may be that on more demanding tasks, 
significant effects of carrying an ε4 allele may be observable. On the switching paradigm 
administered by Velichovsky et al., (2015), ε4+ showed significantly larger switching costs 
than their ε4- counterparts.  
 
Greenwood et al., (2005a) assessed spatial WM in adults, aged 41-85. Relative to ε4-, 
only homozygous ε4+ displayed a disadvantage on spatial WM tasks, driven by performance 
on trials placing the greatest load on spatial WM. In a further study of spatial WM, no 
genotype difference was seen in mid-age adults (Greenwood, Espeseth, Lin, Reinvang, & 
Parasuraman, 2014) 
 
Longitudinal assessments 
 
Several studies have explored how cognition changes longitudinally as a function of 
APOE genotype. Schultz et al. (2008) compared the cognitive test performance of army 
cadets in the 6th decade of life, to their scores on the same measure at age 20, and found ε4+ 
showed greater decline. Across a period of 6 years, relatively limited effects of APOE 
genotype were reported across a selection of cognitive domains (Zhao et al., 2005), with only 
semantic fluency being negatively associated with ε4+ status in females aged 40-49; this 
study reported no genotype differences in a slightly older sample (aged 50-59). 
 
The dominant focus of  longitudinal research has been establishing if ε4+ show a 
differential rate of memory change over time. Several studies suggest that ε4+ show 
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significantly greater memory decline from mid-adulthood (Caselli et al., 2009; Kozauer, 
Mielke, Chan, Rebok, & Lyketsos, 2008), with this effect isolated to delayed memory in two 
studies (Greenwood, Sunderland, Putnam, Levy, & Parasuraman, 2005b; Greenwood et al., 
2014). Performance change across an average of 3.8 years was investigated for measures of 
memory (Jochemsen, Muller, van der Graaf, & Geerlings, 2012), with participants stratified 
by age. Of interest, it was found ε4+ aged 47-57 years showed improvements in recall 
performance, whilst ε4+ aged 58-67 years showed significant decline by the follow-up 
assessment. How change in memory is influenced by the interaction between APOE 
genotype, ethnicity and cardiovascular health has also been explored over a 6 year interval 
(Blair et al., 2005). Negative associations between ε4+ and memory change were small and 
limited to Caucasian adults. There was no interaction between cardiovascular health factors 
(diabetes, hypercholesterolemia, hypertension), APOE genotype and memory change. 
 
Two papers found a non-significant effect of APOE genotype on change in executive 
abilities over time (Greenwood et al., 2014; Jochemsen et al., 2012). There is support, 
however, for the ε4 allele being associated with greater decline in processing speed (Blair et 
al., 2005; Caselli et al., 2011). In a group of Caucasian adults, ε4+ also diagnosed with 
hypercholesterolemia or diabetes showed increased decline on the digit-symbol substitution 
measure of processing speed (Blair et al., 2005). No APOE x Hypertension interaction was 
found for change in processing speed. Verbal fluency scores were maintained in both the 
Caucasian and Afro-American groups included in Blair et al. (2005). 
 
Longitudinal measures (Greenwood et al., 2014) revealed no genotype difference 
across trials with relatively low WM demand. On trials incorporating a mismatch between 
encoded and target stimuli, and hence placing greater demand on WM resources, however, 
performance of ε4+ improved over 3 years, whilst performance of the ε4- group remained 
stable. The observed practice effects in ε4+ were interpreted by the authors to represent 
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compensatory mechanisms during mid-adulthood, and as a result of the increased cognitive 
effort in this group, some ε4+ benefits were still observed. 
 
Discussion  
 
This review highlights the inconsistencies reported for APOE ε4 effects on cognition 
in mid-adulthood. Synthesising the results through meta-analyses, the effect of carrying an ε4 
allele was non-significant across the 7 cognitive domains examined (global cognition, 
memory, executive ability, verbal fluency, language, visuospatial processing, and processing 
speed). Closer inspection of individual studies, however, indicates ε4+ effects may emerge 
under certain conditions, and when probed with measures designed to maximise sensitivity.  
 
The results of the meta-analyses offer limited support for ε4+ showing cognitive 
differences in mid-adulthood; performance of ε4+ and ε4- appears equivalent until the end of 
the 5th decade. This is not inconsistent with the antagonistic pleiotropy position whereby the 
ε4 allele has opposing effects on fitness across the lifespan (Han & Bondi, 2008), with mid-
adulthood as a transition point between ε4+ behavioural advantages in youth switching to 
disadvantages in older adulthood. 
 
When considering individual studies in more detail, the age range of participants is a 
likely factor in the inconsistency between study outcomes. Critically, existing research lacks a 
precise and consistent definition of mid-adulthood, reflected in the diverse and often broad 
age ranges of volunteers participating in the research reviewed here (see Table 1). For 
example, mid-adulthood was defined as 24-69 years in one study (Flory et al., 2000) and 41-
85 years in another (Greenwood et al., 2005a). To draw conclusions of genotype effects at 
any precise window of the lifespan is difficult with such large age inclusion criteria, and the 
disparity in age groups may relate to the inconsistency of results presented. In cases where 
samples were stratified by age, Age x APOE interactions were reported, indicating emergence 
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of the detrimental effects of APOE ε4 in the latter half of the 5th decade (Jochemsen et al., 
2012; Marioni et al., 2016; Shin et al., 2014).  This highlights the importance of controlling 
for age. Age was not included as a moderator in the current meta-analyses due to the small 
number of studies in each domain, but this is certainly an important avenue for future 
research.  
 
A key question for this review was whether process-specific cognitive measures show 
sensitivity to APOE genotype effects in mid-adulthood. Although the results of the meta-
analyses failed to report a robust effect of ε4+ status on memory, looking across studies there 
is a relatively consistent pattern of emerging decrements in ε4+ performance (11/20 studies). 
Detrimental effects of ε4+ status on memory were also supported by longitudinal studies, 
suggesting this genotype group shows an accelerated trajectory of memory decline (Caselli et 
al., 2009; Greenwood et al., 2005; Greenwood et al., 2014; Kozauer et al., 2008). The 
sensitivity of memory to the effects of APOE ε4 from mid-adulthood is further supported by 
imaging evidence of genotype differences in MTL regions, implicating this region as a neural 
basis for behavioural changes (Goveas et al., 2013; Li et al., 2014). Memory is over-
represented in studies probing the effects of APOE, and with more careful consideration of 
other cognitive domains, other effects may emerge. 
 
It is important to consider that many of the study outcomes included in the meta-
analyses were based on neuropsychological assessment performance. It may be that the 
preclinical effects of APOE ε4 are too subtle for detection with neuropsychological measures, 
more commonly used for the detection of clinically relevant symptoms. In support of this, 
studies using computerized paradigms designed to target specific cognitive processes report 
APOE ε4 differences in mid-adulthood within the domains of EF, attention and WM (Evans 
et al., 2013, 2014; Greenwood et al.,, 2000; 2005; 2014; Velichkovsky et al., 2015). These 
domains have also been linked to ε4+ cognitive advantages in early adulthood (Marchant et 
al., 2010; Rusted et al., 2013; Taylor et al., 2016), and so may show early sensitivity to 
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genotype effects. Future research should focus on specific cognitive processes in order to 
establish the pattern of age-related change more clearly. Identifying replicable cognitive 
markers of those at heightened risk of poor cognitive ageing would make a substantial 
contribution to the development of early intervention strategies, independently and in 
association with the study of biomarkers and additional risk factors for dementia. 
 
An additional methodological issue is the role of individual differences in moderating 
the effects of APOE. Several studies attempt to control for differences in ethnicity, education, 
socio-economic status (SES), and health factors; however, these factors are not uniformly 
included. Investigation of how these factors interact with APOE ε4 to alter the initial stages of 
ageing is limited to date. Although methodological shortcomings contribute to the 
inconsistency of findings, it is important to recognise that mid-age itself will play an 
important role.  Mid-age brings with it other risk factors for poor cognitive ageing (e.g. 
hypertension, high cholesterol and diabetes (Atzmon et al., 2002; Köhler et al., 2014; van 
Exel et al., 2002; Whitmer, Sidney, Selby, Johnston, & Yaffe, 2005), and interactions 
between vascular health, APOE and cognition are reported (de Frias, Schaie, & Willis, 2014; 
Peila et al., 2001; Puttonen, Elovainio, Kivimäki, Lehtimäki, & Keltikangas-Järvinen, 2003; 
Zade et al., 2010). Current behavioural research is neither considering the potential modifying 
effects of wider risk factors nor adequately controlling for them, though they undoubtedly 
contribute to the cognitive ageing trajectory (Herrup, 2010). One account for the role of 
APOE ε4 in cognitive ageing is that this allele represents a genetic susceptibility, increasing 
vulnerability to both detrimental and protective factors in cognitive ageing (Wirth, 
Villeneuve, La Joie, Marks, & Jagust, 2014). Mid-adulthood represents a period of the 
lifespan where ε4+ are particularly susceptible to cognitive insults and benefits, and this 
underlines the need to consider the cognitive profile of ε4+ in relation to other potential 
modulators for cognitive health when establishing the preclinical effects of this gene. 
 
Conclusions 
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It remains difficult to untangle the effects of APOE ε4 on cognition in mid-adulthood; 
methodological issues including imprecise criteria for age of volunteers and differential 
sensitivity of the measures used make it hard to form concrete conclusions. Results reviewed 
here suggest the cognitive performance of ε4+ in mid-adulthood is broadly comparable with 
their ε4- counterparts. Subtle differences in memory and executive abilities are reported, 
however, where more sensitive measures of cognition are used, suggestive of the beginnings 
of a differential ageing trajectory in ε4+. Future research should focus on administering 
cognitive paradigms specifically chosen for their ability to sensitively measure the more 
nuanced processes in each particular domain, rather than relying on assessment measures 
more traditional of clinical settings. Since mid-age is a time when the trajectory of cognitive 
ageing will be influenced by multiple factors, these must also be incorporated when 
modelling the effects of APOE ε4 across the lifespan. Through the consideration of these 
factors in future study design reliable cognitive markers for exposing accelerated cognitive 
ageing in mid-adulthood may be developed.  
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Figure Captions 
Figure 1. Flow chart of study selection process for review of APOE effects in mid-adulthood.  
 
Figure 2. Forest plots of weighted effect sizes by cognitive domain. For each study, effect size 
is reported as Hedge’s d [95% CI], where a positive effect size represents greater 
performance by the ε4+ group. 
 
 
 
 
